Skip to main content
Log in

The effect of selective cardiac adrenergicβ-blockade on the hypotensive effect of hydrallazine

  • Specialia
  • Pharmacologica
  • Published:
Experientia Aims and scope Submit manuscript

Zusammenfassung

Es wird gezeigt, dass Verabreichung von Hydrallazin einen Blutdruckabfall und eine reflektorische Tachykardie zur Folge hat. Nach Praktololgabe wird eine Hemmung der reflektorischen Tachykardie erreicht, während die blutdrucksenkende Wirkung erheblich vermindert wird.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. M. Nickerson, inThe Pharmacological Basis of Therapeutics, 3rd edn (Eds.L. S. Goodman andA. Gilman; The MacMillan Company, New York 1965), p. 720.

    Google Scholar 

  2. B. Ablad, Acta Pharmac. Tox.20, Suppl. No. 1, 1 (1963).

    Article  CAS  Google Scholar 

  3. G. Glick andE. Braunwald, Circulation Res.16, 363 (1965).

    Article  CAS  Google Scholar 

  4. H. Brunner, P. R. Hedwall andM. Meier, Br. J. Pharmac.60, 123 (1967).

    Google Scholar 

  5. D. Dunlop andR. G. Shanks, Br. J. Pharmac.32, 201 (1968).

    CAS  Google Scholar 

  6. A. Goldstein,Biostatistics, 1st edn (The MacMillan Company, New York 1964), p. 59.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Acknowledgments. We would like to thank MissMargaret Budden for technical assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dahr, A.S., George, C.F. & Dollery, C.T. The effect of selective cardiac adrenergicβ-blockade on the hypotensive effect of hydrallazine. Experientia 27, 545–546 (1971). https://doi.org/10.1007/BF02147591

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02147591

Keywords

Navigation